Metabolism of Big endothelin-1 (1–38) and (22–38) in the human circulation in relation to production of endothelin-1 (1–21)

Regulatory Peptides - Tập 55 - Trang 287-297 - 1995
A. Hemsén1, G. Ahlborg2, A. Ottosson-Seeberger2, J.M. Lundberg1
1Division of Pharmacology, Department of Physiology and Pharmacology, Karolinska Institute, S-171 77 Stockholm, Sweden
2Department of Clinical Physiology and Nephrology, Huddinge University Hospital, Stockholm, Sweden

Tài liệu tham khảo

Yanagisawa, 1988, A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature (Lond.), 332, 411, 10.1038/332411a0 Miyauchi, 1989, Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction, Lancet, 2, 53, 10.1016/S0140-6736(89)90303-6 Cernacek, 1989, Immunoreactive endothelin in human plasma: marked elevation in patients in cardiogenic shock, Biochem. Biophys. Res. Commun., 161, 562, 10.1016/0006-291X(89)92636-3 Weitzberg, 1991, Longlasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues, Biochem. Biophys. Res. Commun., 180, 1298, 10.1016/S0006-291X(05)81336-1 Löffler, 1992, Concentrations and ratios of immunoreactive big-endothelin-1 and endothelin-1 in human, rat and rabbit plasma, Biochem. Int., 27, 755 Emori, 1989, Concomitant secretion of big endothelin and its c-terminal fragment from human and bovine endothelial cells, Biochem. Biophys. Res. Commun., 162, 217, 10.1016/0006-291X(89)91984-0 Hemsén, 1991, Regional extraction of endothelins and conversion of big endothelin to endothelin-1 in the pig, Acta Physiol. Scand., 141, 319, 10.1111/j.1748-1716.1991.tb09088.x Goodfriend, 1964, Antibodies to bradykinin and angiotensin: a use of carbodiimides in immunology, Science, 144, 1344, 10.1126/science.144.3624.1344 Hemsén, 1991, Presence of endothelin-1 and endothelin-3 in peripheral tissues and central nervous system of the pig, Regul. Pept., 36, 71, 10.1016/0167-0115(91)90196-N Shimada, 1994, Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells, J. Biol. Chem., 269, 18275, 10.1016/S0021-9258(17)32298-6 Opgenorth, 1992, Endothelin-converting enzymes, FASEB J., 6, 2653, 10.1096/fasebj.6.9.1612289 Matsumura, 1990, Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effects of big endothelin-1, Eur. J. Pharmacol., 185, 103, 10.1016/0014-2999(90)90216-S Modin, 1991, Phosphoramidon inhibits the vasoconstrictor effects evoked by big endothelin-1 but not the elevation of plasma endothelin-1 in vivo, Life Sci., 49, 1619, 10.1016/0024-3205(91)90056-H Ohwaki, 1993, Endothelin-converting enzyme activity in human serum lipoprotein fraction, FEBS Lett., 370, 165, 10.1016/0014-5793(93)80084-8 Ahlborg, 1994, Big ET-1 infusion in man causes renal ET-1 release, renal and splanchic vasoconstriction, and increased mean arterial blood pressure, Cardiovasc. Res., 28, 1559, 10.1093/cvr/28.10.1559 Wagner, 1992, Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation, Eur. J. Clin. Invest., 22, 277, 10.1111/j.1365-2362.1992.tb01463.x Weitzberg, 1993, Differences in vascular effects and removal of endothelin-1 in human lung, brain and skeletal muscle, Clin. Physiol., 13, 653, 10.1111/j.1475-097X.1993.tb00480.x